# Glyburide + Metformin

## GlucoMET 5/500mg

#### 一般可用

| 藥品代碼       | OGLUM                                                                                                                                                                                                                                                                                                                                         |
|:---------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | As initial or 2nd-line therapy in the treatment of type 2 diabetes.                                                                                                                                                                                                                                                                           |
| 用法用量       | Initial 0.5-1 TAB once daily， max 4 TAB (20 mg glyburide and 2000 mg metformin).                                                                                                                                                                                                                                                             |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                  |
| 腎功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                    |
| 禁忌           | Renal disease or renal dysfunction， CHF requiring pharmacologic treatment， acute or chronic metabolic acidosis， including diabetic ketoacidosis with or without coma. Treatment should be temporarily discontinued in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials.       |
| 副作用         | GI disturbances， headache， abdominal pain， dizziness. Rarely， lactic acidosis. Endocrine metabolic: Cobalamin deficiency (7% )， Hypoglycemia Gastrointestinal: Abdominal pain (6.9% )， Diarrhea (17% )， Nausea and vomiting (7.6% ) Neurologic: Dizziness (5.5% )， Headache (8.9% ) Respiratory: Upper respiratory infection (17.3% ) |
| 孕期用藥建議   | Human data suggest low risk                                                                                                                                                                                                                                                                                                                   |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                           |

